Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174630 | SCV000225961 | benign | not specified | 2016-06-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000835355 | SCV000977146 | likely benign | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001084775 | SCV001012601 | likely benign | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, |
RCV001640266 | SCV001519232 | benign | Autosomal recessive ataxia, Beauce type | 2021-07-12 | criteria provided, single submitter | research | |
Ce |
RCV000835355 | SCV004700411 | likely benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | SYNE1: BS2 |
Prevention |
RCV003965258 | SCV004785043 | likely benign | SYNE1-related condition | 2019-08-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |